Karen Bernards
Vifor Pharma (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Cancer Research and Treatments, Microtubule and mitosis dynamics
Most-Cited Works
- → CombiMatrix oligonucleotide arrays: Genotyping and gene expression assays employing electrochemical detection(2006)162 cited
- → Immunization with a Polyprotein Vaccine Consisting of the T-Cell Antigens Thiol-Specific Antioxidant,Leishmania majorStress-Inducible Protein 1, andLeishmaniaElongation Initiation Factor Protects against Leishmaniasis(2002)144 cited
- → Identification of Upper Respiratory Tract Pathogens Using Electrochemical Detection on an Oligonucleotide Microarray(2007)72 cited
- → T-Cell Expression Cloning ofPorphyromonas gingivalisGenes Coding for T Helper-Biased Immune Responses during Infection(2006)13 cited
- → Abstract 3590: Profiles of contributing genes to sensitive/resistant phenotypes of 11 different oncology therapeutic agents across 240 cell lines(2010)1 cited
- → Abstract A127: Long-term cell culture models enable drug response determination for epigenetic therapeutics.(2013)1 cited
- → 240 human tumor cell line profiling to evaluate relationships between tumor genotypes and cancer cell sensitivity(2010)1 cited
- → Abstract 2036: OncoPanel 3D: High-content characterization of 240 three-dimensional tumor spheroids for drug response profiling and biomarker discovery(2014)1 cited
- → Abstract 3141: High-content live-cell imaging analysis of therapeutic monoclonal antibody binding and potency across 240 genomically defined cancer cell lines.(2013)1 cited
- → Abstract C168: Use of cellular antibody binding data to guide assessment of monoclonal antibodies as potential antibody-drug conjugates.(2013)